Skip to main content
PS

PHIO scientific

This company provides continuous, non-invasive cell monitoring through the integration of ultra-compact Cellwatchers and the PHIOme cloud-based AI platform. This system automates the tracking of cell growth, viability, motility, and drug response directly within the incubator. The result is objective, processed data delivered automatically, reducing manual workload and improving assay quality.

Munich, GermanyFounded 2020203K+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional cell culture monitoring relies on manual, labor-intensive methods and endpoint assays, providing limited real-time data on cell growth, viability, and behavior within incubators. These methods are prone to variability, can disrupt the cell culture environment, and often miss critical events during experiments.

Solution

PHIO Scientific offers PHIOme, a cloud-based AI platform integrated with lensless Cellwatchers for continuous, non-invasive monitoring of cell cultures directly within incubators. The system provides real-time, objective data on cell growth, viability, motility, phenotype, and drug response, eliminating the need for manual cell counting and disruptive sampling. By automating data acquisition, analysis, and visualization, PHIOme reduces manual labor, minimizes variability, and improves the reproducibility of cell culture experiments. Researchers gain access to publication-ready results through a user-friendly cloud interface, enabling data-driven decisions and optimized cell culture conditions.

Target Audience

The primary target audience includes researchers in cancer research, drug discovery, immunology, and other life science fields who require continuous, objective data on cell cultures for improved reproducibility and efficiency.

Features

  • Lensless Cellwatchers for continuous, non-invasive imaging inside standard cell culture incubators
  • Real-time monitoring of cell growth, viability, motility, phenotype, and drug response
  • Cloud-based AI platform (PHIOme) for automated image analysis and data processing
  • Publication-ready plots, maps, videos, and documentation accessible through a web browser
  • Automated data transfer, backup, analysis, and visualization
  • Non-disruptive monitoring to maintain a stable cell culture environment and reduce contamination risk
  • User-friendly interface with no manual settings required
This profile is AI-generated and may contain inaccuracies.